Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study.
Andrew IpJaeil AhnYizhao ZhouAndre H GoyEric HansenAndrew L PecoraBrittany A SinclaireUrszula BednarzMichael MarafeliasIhor S SawczukJoseph P UnderwoodDavid M WalkerRajiv PrasadRobert L SweeneyMarie G PonceSamuel La CapraFrank J CunninghamArthur G CaliseBradley L PulverDominic RuoccoGreggory E MojaresMichael P EaganKristy L ZiontzPaul MastrokyriakosStuart L GoldbergPublished in: BMC infectious diseases (2021)
In this retrospective observational study of SARS-CoV-2 infected non-hospitalized patients hydroxychloroquine exposure was associated with a decreased rate of subsequent hospitalization. Additional exploration of hydroxychloroquine in this mildly symptomatic outpatient population is warranted.